Company Information

  

Address: C/O MOURANT OZANNES CORPORATE SERVICES
94 SOLARIS AVENUE, CAMANA BAY 
City: GRAND CAYMAN 
State:  
Zip Code: KY1-1108 
Telephone: 13459494123 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a globally focused, clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. We believe the next generation of cancer treatment will utilize therapeutics both as monotherapies and in combination to attack multiple underlying mechanisms of cancer cell growth and survival. We further believe that discovery of next-generation cancer therapies requires new research tools. To that end, we have developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support our drug discovery effort. Our strategy is to develop a pipeline of drug candidates with the potential to be best-in-class monotherapies and also important components of multiple-agent combination regimens.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-0.08NAN/E
06/2017-0.39NAN/E
03/2017-0.33NAN/E
12/2016-0.30NAN/E
09/2016-0.07NAN/E
06/2016-0.02NAN/E
03/2016-0.02NAN/E
12/2015--NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.20Total Liab/Total Assets0.13
Net Inc/Total Assets-0.29Total Liab/Inv Cap0.14
Net Inc/Inv Cap-0.32Total Liab/Comm Equity0.09
Pretax Inc/Net Sales-111.37Interest Coverage RatioNA
Net Inc/Net Sales-111.42Curr Debt/EquityNA
Cash Flow/Net Sales-83.66LTD/Equity0.05
SG&A/NetSales18.78Total Debt/Equity0.05
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio10.68
Inventory TurnoverNACurrent Ratio10.68
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work Cap0.00Inv/Curr AssetsNA
Net Sales/PP&E0.04  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) 220.21 0.00 0.00 0.00
Cost of Goods Sold 1.94 NA NA 0.00
Selling & Admin Exps 15.64 10.78 8.77 8.34
Operating Income 114.91 -58.02 -51.54 -37.27
Interest Exp NA NA NA NA
Pretax Income 114.22 -60.48 -50.44 -37.85
Other Income 1.10 -0.66 1.10 -0.63
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 117.39 -60.55 -50.62 -37.60

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 757.44 407.43 327.48 368.17
Receivables - Total 181.47 NA NA NA
Inventories - Total 5.71 NA NA NA
Total Current Assets 962.33 418.69 336.18 374.40
Net Property, Plant & Equipment 55.32 33.77 30.72 25.98
Total Assets 1,049.06 473.98 376.73 405.81
Liabilities        
Accounts Payable 85.01 49.95 47.52 35.06
Debt in Current Liabilities 9.02 NA 2.47 0.00
Total Current Liabilities 103.16 49.95 49.99 35.06
Long-Term Debt 149.33 152.73 17.43 17.28
Total Liabilities 298.92 218.22 68.31 52.91
Stockholder's Equity        
Minority Interest 14.35 14.42 NA NA
Preferred Stock NA NA NA NA
Common Stock 0.06 0.05 0.05 0.05
Retained Earnings -231.19 -348.58 -288.04 -237.41
Treasury Stock NA NA NA NA
Total Stockholders' Equity 750.14 255.75 308.42 352.91
Total Liabilities and Stockholders' Equity 1,049.06 473.98 376.73 405.81

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities 6.60 -51.89 -35.71 -26.14
Net Cash Provided by Investing Activities -401.33 69.71 43.54 -170.72
Net Cash Provided by Financing Activities 339.71 145.07 2.53 198.69

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201311.15-7.49--
12/201413.04-18.28--
12/20158.82-57.10--
12/20161.07-119.22-0.30
Growth Rates-54.21----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/178725,1754.26




Report Date : 12/11/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.